Find clinical trials for Adenocarcinoma in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma

Cancer

Pancreatic Cancer

Stomach Cancer

Colorectal Cancer

Prostatic Cancer

Esophageal Cancer

Adenocarcinoma trials near Aurora, CO, USA:

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

The objective of this study is to estimate the R0 resection rate in patients with Resectable Pancreatic Ductal Adenocarcinoma (R-PDAC) as we...

Active, not recruiting

Pancreatic Adenocarcinoma

Pancreas Ductal Adenocarcinoma

Drug: Nab paclitaxel

Drug: Gemcitabine

Phase 2

Criterium

Aurora, Colorado, United States and 3 other locations

PT886 For Treatment of Patients With Metastatic/Advanced Gastric, Gastroesophageal Junction and Pancreatic Adenocarcinoma (the TWINPEAK Study)

will be eligible for screening: unresectable or metastatic gastric adenocarcinoma, gastroesophageal junction (GEJ) adenocarcinoma, ...

Enrolling

Pancreatic Ductal Adenocarcinoma

Gastric or Gastroesophageal Junction Adenocarcinoma

Drug: KEYTRUDA® (pembrolizumab)

Drug: Gemcitabine

Phase 1, Phase 2

Phanes Therapeutics

Denver, Colorado, United States and 3 other locations

FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer

The purpose of this study is to find out if an experimental drug will prevent metastatic pancreatic adenocarcinoma from becoming resistant t...

Enrolling

Pancreatic Adenocarcinoma Metastatic

Pancreatic Adenocarcinoma

Drug: FOLFIRNINOX

Drug: 9-ING-41

Phase 2

Colin D. Weekes, M.D., PhD

Aurora, Colorado, United States and 2 other locations

A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

The aim of this study is to characterize the safety and tolerability of MORAb-202, and to assess the objective response rate in participants with pre...

Enrolling

Carcinoma, Non-Small-Cell Lung

Drug: MORAb-202

Phase 2

Bristol-Myers Squibb (BMS)

Lone Tree, Colorado, United States and 32 other locations

A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...

Enrolling

Endometrial Adenocarcinoma

Urothelial Carcinoma

Drug: ACR-368

Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Aurora, Colorado, United States and 67 other locations

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (AMPLIFY-201)

This is a Phase 1 study to assess the safety and efficacy of ELI-002 immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide [Amph-CpG-7...

Active, not recruiting

Pancreatic Ductal Adenocarcinoma

NRAS G12D

Drug: ELI-002 2P

Phase 1

Elicio Therapeutics

Aurora, Colorado, United States and 9 other locations

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

mCRPC. Patients enrolled in the Phase 2a portion of the study will have either Small Cell Neuroendocrine Prostate Cancer(SCNC)(Cohort A) or adenocarcinoma...

Active, not recruiting

Small Cell Carcinoma

Neuroendocrine Tumors

Drug: BXCL701 monotherapy

Drug: BXCL701 plus Pembrolizumab

Phase 1, Phase 2

BioXcel Therapeutics

Denver, Colorado, United States and 11 other locations

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer (MOUNTAINEER-02)

This study is being done to see if tucatinib with trastuzumab, ramucirumab and paclitaxel works better than ramucirumab and paclitaxel to treat HER2-...

Active, not recruiting

Esophageal Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma

Drug: paclitaxel

Drug: trastuzumab

Phase 2, Phase 3

Seagen

Aurora, Colorado, United States and 47 other locations

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody ta...

Enrolling

Colorectal Adenocarcinoma

Pancreatic Adenocarcinoma

Drug: 5-fluorouracil

Drug: Irinotecan

Phase 1

Inhibrx

Aurora, Colorado, United States and 18 other locations

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer (Spotlight)

unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Why is this study being done? SPOTLIGHT is a new clinical st...

Active, not recruiting

Metastatic Gastric Adenocarcinoma or Cancer

Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer

Drug: placebo

Drug: oxaliplatin

Phase 3

Astellas

Aurora, Colorado, United States and 219 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Adenocarcinoma in .css-epvm6{white-space:nowrap;}Aurora, CO

Related conditions:

Adenocarcinoma trials near Aurora, CO, USA:

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

PT886 For Treatment of Patients With Metastatic/Advanced Gastric, Gastroesophageal Junction and Pancreatic Adenocarcinoma (the TWINPEAK Study)

FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer

A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (AMPLIFY-201)

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer (MOUNTAINEER-02)

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer (Spotlight)

Find clinical trials for Adenocarcinoma in Aurora, CO